Marcus Conant

Marcus Augustine Conant (born May 11, 1936, in Jacksonville, Florida) is an American dermatologist and one of the first physicians to diagnose and treat Acquired Immune Deficiency Syndrome (AIDS) in 1981.

He helped create one of the largest private AIDS clinics, was a founder of the San Francisco AIDS Foundation, and his work contributed to development of some of today's top HIV medications.

He has written over 70 publications on the treatment of AIDS.

Marcus Augustine Conant was born on May 11, 1936, in Jacksonville, Florida, to Marcus and Annie Long Conant.

His father was in the military, leading to Marcus moving around a lot during his early years.

When his father was deployed to Europe, Marcus and his family moved back to Jacksonville, Florida where he attended high school.

Conant then attended Duke University where he graduated in 1957 with a B.S. in Zoology.

In 1961, Conant graduated from Duke University College of Medicine with a specialty in Dermatology and interned at Duke University Medical Center.

Conant served in the United States Air Force as a flight surgeon, on active duty from 1962 to 1964, and continuing as a reservist until 1967.

In 1964, Conant joined the University of California San Francisco Medical Center as a dermatology resident.

In 1967, he received his first academic appointment, as an instructor in clinical dermatology.

As a resident at UCSF, Conant also volunteered at the Haight Ashbury Free Clinics, where he treated patients with genital herpes.

Conant founded the Kaposi's Sarcoma Research & Education Foundation in May 1982, which quickly became the first multidisciplinary AIDS clinic, and is now known today as the San Francisco AIDS Foundation.

Over the years, Conant rose up the academic ladder, and in 1984, he was appointed as clinical professor of dermatology.

While he was an associate professor at UCSF, Conant first identified Kaposi's Sarcoma and AIDS in patients, including early AIDS activist Bobbi Campbell.

In 1987, Conant was appointed as co-chair of the California AIDS Leadership Committee, where he created California's initial policies in response to the AIDS epidemic.

He was the lead plaintiff in the Walters vs. Conant trial, which lead to the judicial decision protecting the First Amendment right of physicians to recommend the use of medical marijuana to people living with HIV and AIDS, as well as the right to talk to their patients about anything as long as it was in the privacy of the examination room.

In 2010, Conant closed his practice in San Francisco, where he cared for over 8,000 patients with HIV/AIDS, and moved to New York, citing rising costs and difficulties in dealing with health insurance companies.

He stated, "I'm sorry to have to leave my patients, and a lot of them are sorry I had to leave, but it's time. This is only symptomatic of a much bigger problem we have in this country with health care."

He continued to consult with researchers on a reported association of a virus with chronic fatigue syndrome and autism.

In August 2021, Conant was appointed as a special advisor to the CEO at American Gene Technologies (AGT), a biotechnology company in Rockville, Maryland who is focused on using gene therapy to find a cure for a variety of diseases, including HIV.

Conant was eventually moved up to the role of Chief Medical Officer (CMO) at American Gene Technologies in October 2021, where he oversees the clinical trials for AGT's potential HIV cure therapy, AGT103-T.